Prevalence of breast malignancy in women older than forteen years who consulted for solid palpable mass
Prevalencia de patología maligna de seno en mujeres mayores de 14 años que consultaron por masa sólida palpable
Article Sidebar
PDF (Español (España))
FLIP
How to Cite
Guio Ávila, J. I., Pedraza Neisa, E. J., Guzmán Castro, W. E., García, O. A., Corena Días, A., & Villamizar, L. (2017). Prevalence of breast malignancy in women older than forteen years who consulted for solid palpable mass. Journal of Medicine and Surgery Repertoire, 26(3), 165–171. Retrieved from https://revistas.fucsalud.edu.co/index.php/repertorio/article/view/45
Published:
Sep 1, 2017
Section
Research Article
License terms
Main Article Content
Abstract
Objective: To determine the prevalence rate of malignancy in patients with no prior breast cancer diagnosis who consulted for a solid palpable mass in two hospitals in Bogotá, Colombia.
Materials and methods: A descriptive retrospective study conducted between March 2010 and February 2013 at San José and Infantil Universitario de San José hospitals in Bogotá D. C., Colombia. Women 14 years or older with no prior breast cancer diagnosis who consulted for a palpable solid mass, confirmed by physical exam, were included. No exclusion criteria were considered. Data was collected from the clinical records and included in a format created by the researchers. Stata 13 was used for data analysis.
Results: The mass was confirmed by physical exam in 342 patients and by a biopsy in 307 patients. The prevalence rate for malignancy was 12.2% and for benign masses 71.66%.
Discussion: Our prevalence of breast cancer associated with a palpable mass was less than worldwide reported prevalence. The most frequent malignancy was invasive ductal carcinoma in 87% and invasive lobular carcinoma in 6.4% in stage IIA and BI-RADS 4 A ultrasound category and BI-RADS 4 B mammogram category.
Downloads
Download data is not yet available.
Article Details
References
1. International Agency For Research on Cancer. WHO Globocan 2012, estimated cancer incidence, Mortality and Prevalence Worldwide 2012. France: WHo; 2012 [consultado 21 Jun 2017]. Disponible en: http://globocan.iarc.fr/Pages/fact sheets population.aspx.
2. Motivo de consulta mas frecuente en Cirugía de seno de los servicio de Ginecología y Obstetricia y Cirugía General. Sociedad de Cirugía de Bogotá, Hospital San José. Estadística institucional.2011-2013.
3. Alsanabani JA, Gilan W, Saadi AA. Incidence data for breast cancer among Yemeni female patients with palpable breast lumps. Asian Pac J Cancer Prev. 2015;16:191–4.
4. Mittendorf KKHEA. Sabiston Textbook of Surgery. Diseases of the Breast. En: Elsevier, editor. Twentieth Edition 2017. p. 819-64.
5. Ikeda KKMyDM. Mammographic and ultrasound analysis of breast masses. En: Elsevier, editor. Breast Imaging: The Requisites. Third Edition 2017. p. 122-70.
6. Luis Betancourt NC, Yozelyn Pinto LB, Claudia González FD, Gabriel Romero PM, Denise Mattar AV. Perfil clínico patológico de pacientes del servicio de patología mamaria. Rev Venez Oncol. 2008;20:186–91.
7. Orel SG, Kay N, Reynolds C, Sullivan DC. BI-RADS categorization as a predictor of malignancy. Radiology. 1999;211:845–50.
8. Zapardiel Gutiérrez I, Schneider Fontán J. ¿Sabemos qué causa el cáncer de mama? Influencia actual de los diferentes factores de riesgo. POG Progresos de obstetricia y ginecología. 2009;52:595–608.
9. Morrow M. The evaluation of common breast problems. Am Fam Physician. 2000;61:2371–8, 85.
10. Klein S. Evaluation of palpable breast masses. Am Fam Physician. 2005;71:1731–8.
11. Jaeger BM, Hong AS, Letter H, Odell MC. Advancements in Imaging Technology for Detection and Diagnosis of Palpable Breast Masses. Clin Obstet Gynecol. 2016;59:336–50.
12. Salzman B, Fleegle S, Tully AS. Common breast problems. Am Fam Physician. 2012;86:343–9.
13. Angarita FAS. Cáncer de seno: de la epidemiología al tratamiento. Univ Méd. 2008;49:344–72.
14. Cancerología. INd. Recomendaciones para la detección temprana de cáncer de mama en Colombia. 2006.
15. Hernández-Cruz BZAJ, González-Ávila G. Biopsia por aspiración con aguja fina comparada con aguja de corte en el diagnóstico de cáncer de mama. Gaceta Mexicana de Oncología. 2012:137–44.
16. Gallego G. Nódulo palpable de mama. Rev Colomb Obstet Ginecol. 2005;56:82–91.
17. Cedolini C, Bertozzi S, Londero AP, Bernardi S, Seriau L, Concina S, et al. Type of breast cancer diagnosis, screening, and survival. Clin Breast Cancer. 2014;14:235–40.
18. García OGJ, Guarnizo L. Prevalencia de patología maligna de seno en mujeres mayores de 14 años. Repert Med Cir. 2011;20:103–10.
19. Angarita FAAS, Torregrosa L, Tawil M, Ruiz ÁJ. Initial presentation of patients with diagnosis of breast cancer at the Centro Javeriano de Oncología of Hospital Universitario San Ignacio. Rev Colomb Cir. 2010;25:19–26.
20. Haakinson DJ, Stucky CC, Dueck AC, Gray RJ, Wasif N, Apsey HA, et al. A significant number of women present with palpable breast cancer even with a normal mammogram within 1 year. Am J Surg. 2010;200:712–7, discussion 7-8.
21. Harvey JA, Mahoney MC, Newell MS, Bailey L, Barke LD, D’Orsi C, et al. ACR appropriateness criteria palpable breast masses. J Am Coll Radiol. 2013;10:742–9, e1-3.
22. Feig WBH, Fuhrman M. Cáncer de mama invasivo y cáncer de mama no invasivo. quirúrgica O e, editor. Madrid: Marbán Libros; 2005.
23. Pruthi S. Detection and evaluation of a palpable breast mass. Mayo Clin Proc. 2001;76:641–7, quiz 7-8.
24. Ezer SS, Oguzkurt P, Ince E, Temiz A, Bolat FA, Hicsonmez A. Surgical treatment of the solid breast masses in female adolescents. J Pediatr Adolesc Gynecol. 2013;26:31–5.
25. Meisner AL, Fekrazad MH, Royce ME. Breast disease: benign and malignant. Med Clin North Am. 2008;92:1115–41.
26. Onstad M, Stuckey A. Benign breast disorders. Obstet Gynecol Clin North Am. 2013;40:459–73.
27. Ahmed M, Douek M. The management of screen-detected breast cancer. Anticancer Res. 2014;34:1141–6.
2. Motivo de consulta mas frecuente en Cirugía de seno de los servicio de Ginecología y Obstetricia y Cirugía General. Sociedad de Cirugía de Bogotá, Hospital San José. Estadística institucional.2011-2013.
3. Alsanabani JA, Gilan W, Saadi AA. Incidence data for breast cancer among Yemeni female patients with palpable breast lumps. Asian Pac J Cancer Prev. 2015;16:191–4.
4. Mittendorf KKHEA. Sabiston Textbook of Surgery. Diseases of the Breast. En: Elsevier, editor. Twentieth Edition 2017. p. 819-64.
5. Ikeda KKMyDM. Mammographic and ultrasound analysis of breast masses. En: Elsevier, editor. Breast Imaging: The Requisites. Third Edition 2017. p. 122-70.
6. Luis Betancourt NC, Yozelyn Pinto LB, Claudia González FD, Gabriel Romero PM, Denise Mattar AV. Perfil clínico patológico de pacientes del servicio de patología mamaria. Rev Venez Oncol. 2008;20:186–91.
7. Orel SG, Kay N, Reynolds C, Sullivan DC. BI-RADS categorization as a predictor of malignancy. Radiology. 1999;211:845–50.
8. Zapardiel Gutiérrez I, Schneider Fontán J. ¿Sabemos qué causa el cáncer de mama? Influencia actual de los diferentes factores de riesgo. POG Progresos de obstetricia y ginecología. 2009;52:595–608.
9. Morrow M. The evaluation of common breast problems. Am Fam Physician. 2000;61:2371–8, 85.
10. Klein S. Evaluation of palpable breast masses. Am Fam Physician. 2005;71:1731–8.
11. Jaeger BM, Hong AS, Letter H, Odell MC. Advancements in Imaging Technology for Detection and Diagnosis of Palpable Breast Masses. Clin Obstet Gynecol. 2016;59:336–50.
12. Salzman B, Fleegle S, Tully AS. Common breast problems. Am Fam Physician. 2012;86:343–9.
13. Angarita FAS. Cáncer de seno: de la epidemiología al tratamiento. Univ Méd. 2008;49:344–72.
14. Cancerología. INd. Recomendaciones para la detección temprana de cáncer de mama en Colombia. 2006.
15. Hernández-Cruz BZAJ, González-Ávila G. Biopsia por aspiración con aguja fina comparada con aguja de corte en el diagnóstico de cáncer de mama. Gaceta Mexicana de Oncología. 2012:137–44.
16. Gallego G. Nódulo palpable de mama. Rev Colomb Obstet Ginecol. 2005;56:82–91.
17. Cedolini C, Bertozzi S, Londero AP, Bernardi S, Seriau L, Concina S, et al. Type of breast cancer diagnosis, screening, and survival. Clin Breast Cancer. 2014;14:235–40.
18. García OGJ, Guarnizo L. Prevalencia de patología maligna de seno en mujeres mayores de 14 años. Repert Med Cir. 2011;20:103–10.
19. Angarita FAAS, Torregrosa L, Tawil M, Ruiz ÁJ. Initial presentation of patients with diagnosis of breast cancer at the Centro Javeriano de Oncología of Hospital Universitario San Ignacio. Rev Colomb Cir. 2010;25:19–26.
20. Haakinson DJ, Stucky CC, Dueck AC, Gray RJ, Wasif N, Apsey HA, et al. A significant number of women present with palpable breast cancer even with a normal mammogram within 1 year. Am J Surg. 2010;200:712–7, discussion 7-8.
21. Harvey JA, Mahoney MC, Newell MS, Bailey L, Barke LD, D’Orsi C, et al. ACR appropriateness criteria palpable breast masses. J Am Coll Radiol. 2013;10:742–9, e1-3.
22. Feig WBH, Fuhrman M. Cáncer de mama invasivo y cáncer de mama no invasivo. quirúrgica O e, editor. Madrid: Marbán Libros; 2005.
23. Pruthi S. Detection and evaluation of a palpable breast mass. Mayo Clin Proc. 2001;76:641–7, quiz 7-8.
24. Ezer SS, Oguzkurt P, Ince E, Temiz A, Bolat FA, Hicsonmez A. Surgical treatment of the solid breast masses in female adolescents. J Pediatr Adolesc Gynecol. 2013;26:31–5.
25. Meisner AL, Fekrazad MH, Royce ME. Breast disease: benign and malignant. Med Clin North Am. 2008;92:1115–41.
26. Onstad M, Stuckey A. Benign breast disorders. Obstet Gynecol Clin North Am. 2013;40:459–73.
27. Ahmed M, Douek M. The management of screen-detected breast cancer. Anticancer Res. 2014;34:1141–6.